# Pazopanib

NDC: 63304-116
Generic name: Pazopanib
Labeler / Manufacturer: SUN PHARMACEUTICAL INDUSTRIES, INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20231020

FDA application: ANDA215837

## Active ingredients

- PAZOPANIB HYDROCHLORIDE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63304-116"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63304-116
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3e8dd09-d7d2-43da-8f63-bdf0ea0fcdf5